ArticleCureus2026
Losartan-Induced Sprue-Like Enteropathy Presenting With Isolated Ileal Villous Atrophy: A Report of a Rare and Atypical Case.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sprue-like enteropathy associated with angiotensin II receptor blockers (ARBs) is a rare cause of chronic diarrhea and malabsorption, typically characterized by villous atrophy and intraepithelial lymphocytosis mimicking celiac disease. Although olmesartan is the most frequently implicated agent, cases associated with other ARBs, including losartan, have increasingly been recognized. A 61-year-old woman with hypertension treated with losartan for three years presented with a three-month history of abdominal pain and chronic diarrhea. Upper endoscopy revealed a macroscopically and histologically normal duodenum. Colonoscopy demonstrated macroscopically normal ileal mucosa; however, ileal biopsies showed villous atrophy and marked intraepithelial lymphocytosis. Celiac serology was negative, infectious causes were excluded, and vitamin B12 deficiency was documented. In the setting of chronic exposure to losartan and after exclusion of alternative etiologies, ARB-associated sprue-like enteropathy was suspected. Losartan was discontinued and replaced with amlodipine, resulting in complete clinical resolution. This case highlights an atypical presentation of losartan-induced sprue-like enteropathy with isolated ileal involvement and a histologically normal duodenum. Clinicians should consider this entity in patients presenting with chronic diarrhea and seronegative villous atrophy, even in the absence of duodenal involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.